- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Nanotech Sciences Corp. (the "Corporation") (TSX VENTURE:NAN.P), a capital pool company, announced today that it has been delayed in filing its unaudited interim financial statements and interim Management Discussion & Analysis ("MD&A") related thereto for the interim period ended December 31, 2007 by the required filing date under applicable Canadian Securities laws (NI-51-102), namely February 29, 2008. The Corporation filed its interim financial statements and associated MD&A on March 4, 2008.
For additional information on the Corporation, please see the prospectus of the Corporation dated December 13, 2007.
Investors are cautioned that trading in the securities of a capital pool company should be considered highly speculative.
Certain information regarding the Corporation set forth in this document, including management's assessment of the Corporation's future plans and operations may constitute forward-looking statements under applicable securities laws and necessarily involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties. The Corporation's actual results, performance or achievement could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what benefits that the Corporation will derive therefrom. All subsequent forward-looking statements, whether written or oral, attributable to the Corporation or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements.
The forward-looking statements contained in this document are made as at the date of this news release and the Corporation does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws.
Nanotech Sciences Corp.
President and Chief Executive Officer
(416) 369-0602 (FAX)
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Explaining how 2-D materials break at the atomic level January 20th, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016